The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Curcumin Nanoformulations for Colorectal Cancer: A Review
Open accessAbstract
Colorectal cancer (CRC) is the third most prevalent form of cancer, after lung cancer and breast cancer, with the second highest death incidence. Over the years, natural compounds have been explored as an alternative to conventional cancer therapies such as surgery, radiotherapy, and chemotherapy. Curcumin, an active constituent of turmeric has been associated with various health benefits. It has gained much attention as an anticancer agent due to its ability to regulate multiple cell signaling pathways, including NF-κB, STAT3, activated protein-1 (AP-1), epidermal growth response-1 (Egr-1), and p53, which are crucial in cancer development and progression. Nevertheless, the clinical application of curcumin is greatly restricted because of its low water solubility, poor oral absorption, and rapid metabolism. These issues have led to the development of curcumin nanoformulations to overcome the limitations of the compound. Nanotechnology-based delivery systems have been widely used in improving the delivery of poorly-water soluble drugs. Besides, these systems also come with the added benefits of possible cellular targeting and improvement in cellular uptake. An ideal improved formulation should display a greater anticancer activity compared to free curcumin, and at the same time be non-toxic to the normal cells. In this review, we focus on the design and development of various nanoformulations to deliver curcumin for use in CRC such as liposomes, micelles, polymer nanoparticles, nanogels, cyclodextrin complexes, solid lipid nanoparticles (SLN), phytosomes, and gold nanoparticles. We also discuss the current pre-clinical and clinical evidences of curcumin nanoformulations in CRC therapy, analyse the research gap, and address the future direction of this research area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Phytosomal curcumin inhibits tumor growth in colitis‐associated colorectal cancer
Marjaneh, R. M., Rahmani, F., Hassanian, S. M., Rezaei, N., Hashemzehi, M., Bahrami, A., Ariakia, F., Fiuji, H., Sahebkar, A., Avan, A., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26538 · Cited by 200
RetractedBioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543 · cited 2×
“However, clinical use of CUR is often restricted due to its low water solubility, resulting in poor absorption following oral administration (Anand et al., 2007).”
BackgroundColorectal cancer statistics, 2017
Siegel, R. L., Miller, K. D., Fedewa, S. A., Ahnen, D. J., Meester, R. G. S., Barzi, A., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21395 · Cited by 3,806
Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors
Haggar, F., & Boushey, R. (2009) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0029-1242458 · Cited by 2,011
The Essential Medicinal Chemistry of Curcumin
Nelson, K. M., Dahlin, J. L., Bisson, J., Graham, J., Pauli, G. F., & Walters, M. A. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00975 · Cited by 1,956
Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers
Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R., & Srinivas, P. (1998) · Planta Medica · doi:10.1055/s-2006-957450 · Cited by 1,656
The Chemistry of Curcumin: From Extraction to Therapeutic Agent
Priyadarsini, K. (2014) · Molecules · doi:10.3390/molecules191220091 · Cited by 1,510
Chemistry: Chemical con artists foil drug discovery
Baell, J., & Walters, M. A. (2014) · Nature · doi:10.1038/513481a · Cited by 1,043
Naksuriya, O., Okonogi, S., Schiffelers, R. M., & Hennink, W. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.090 · Cited by 841
Tønnesen, H. H., Másson, M., & Loftsson, T. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00323-x · Cited by 767
Zhou, H., S. Beevers, C., & Huang, S. (2011) · Current Drug Targets · doi:10.2174/138945011794815356 · Cited by 715
Sandur, S. K., Pandey, M. K., Sung, B., Ahn, K. S., Murakami, A., Sethi, G., Limtrakul, P., Badmaev, V., & Aggarwal, B. B. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm123 · Cited by 687
Colorectal cancer development and advances in screening
Balchen, V., & Simon, K. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s109285 · Cited by 665
Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC–MS/MS
Yang, K.-Y., Lin, L.-C., Tseng, T.-Y., Wang, S.-C., & Tsai, T.-H. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.03.010 · Cited by 635
A Study on the Fate of Curcumin in the Rat
Wahlström, B., & Blennow, G. (1978) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1978.tb02240.x · Cited by 625
Ireson, C. R., Orr, S., Jones, D. J. L., Verschoyle, R. D., Lim, C. K., Luo, J., Howells, L. M., Plummer, S. M., Jukes, R., Williams, M. L., et al. (2001) · PubMed · Cited by 588
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers
Torchilin, V. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.026 · Cited by 583
Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects
Vareed, S. K., Kakarala, M., Ruffin, M. T., Crowell, J. A., Normolle, D. P., Djuric, Z., & Brenner, D. E. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2693 · Cited by 582
Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent
Krausz, A. E., Adler, B. L., Cabral, V., Navati, M., Doerner, J., Charafeddine, R. A., Chandra, D., Liang, H., Gunther, L., Clendaniel, A., et al. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.09.004 · Cited by 515
Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo
Gou, M., Men, K., Shi, H., Xiang, M., Zhang, J., Song, J., Long, J., Wan, Y., Luo, F., Zhao, X., et al. (2011) · Nanoscale · doi:10.1039/c0nr00758g · Cited by 438
Therapeutic Applications of Curcumin Nanoformulations
Yallapu, M. M., Nagesh, P. K. B., Jaggi, M., & Chauhan, S. C. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9811-z · Cited by 392
Anti cancer effects of curcumin: cycle of life and death
Sa, G., & Das, T. (2008) · Cell Division · doi:10.1186/1747-1028-3-14 · Cited by 382
Potential anticancer properties and mechanisms of action of curcumin.
Vallianou, N. G., Evangelopoulos, A. A., Schizas, N., & Kazazis, C. E. (2015) · PubMed · Cited by 333
Li, L., Ahmed, B., Mehta, K., & Kurzrock, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0556 · Cited by 332
Curcumin mediates anticancer effects by modulating multiple cell signaling pathways
Kunnumakkara, A. B., Bordoloi, D., Harsha, C., Banik, K., Gupta, S. C., & Aggarwal, B. B. (2017) · Clinical Science · doi:10.1042/cs20160935 · Cited by 332
Chen, A., Xu, J., & Johnson, A. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209019 · Cited by 301
Asai, A., & Miyazawa, T. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00868-7 · Cited by 291
Curcumin uptake and metabolism
Metzler, M., Pfeiffer, E., Schulz, S. I., & Dempe, J. S. (2013) · BioFactors · doi:10.1002/biof.1042 · Cited by 268
Fujisawa, S., Atsumi, T., Ishihara, M., & Kadoma, Y. (2004) · PubMed · Cited by 229
Recent advances in curcumin nanoformulation for cancer therapy
Lee, W.-H., Loo, C.-Y., Young, P. M., Traini, D., Mason, R. S., & Rohanizadeh, R. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.916686 · Cited by 229
Theoretical study on physicochemical properties of curcumin
Shen, L., & Ji, H.-F. (2007) · Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2006.08.018 · Cited by 220
JIN, H., QIAO, F., WANG, Y., XU, Y., & SHANG, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.4258 · Cited by 210
Curcumin Nanomedicine: A Road to Cancer Therapeutics
M. Yallapu, M., Jaggi, M., & C. Chauhan, S. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805289219 · Cited by 191
Yang, X., Li, Z., Wang, N., Li, L., Song, L., He, T., Sun, L., Wang, Z., Wu, Q., Luo, N., et al. (2015) · Scientific Reports · doi:10.1038/srep10322 · Cited by 179
Unraveling Curcumin Degradation
Gordon, O. N., Luis, P. B., Sintim, H. O., & Schneider, C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.618785 · Cited by 169
Xiang, D., Shigdar, S., Yang, W., Duan, W., Li, Q., Lin, J., Liu, K., & Li, L. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s59779 · Cited by 167
Xiao, B., Si, X., Han, M. K., Viennois, E., Zhang, M., & Merlin, D. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01245g · Cited by 160
Low, L. E., Tan, L. T.-H., Goh, B.-H., Tey, B. T., Ong, B. H., & Tang, S. Y. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.01.037 · Cited by 159
Self-citationAnitha, A., Sreeranganathan, M., Chennazhi, K. P., Lakshmanan, V., & Jayakumar, R. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.04.017 · Cited by 156
Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles
Chuah, L., Roberts, C. J., Billa, N., Abdullah, S., & Rosli, R. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.01.007 · Cited by 156
Self-citationCurcumin and tumor immune-editing: resurrecting the immune system
Bose, S., Panda, A. K., Mukherjee, S., & Sa, G. (2015) · Cell Division · doi:10.1186/s13008-015-0012-z · Cited by 155
Xiao, B., Han, M. K., Viennois, E., Wang, L., Zhang, M., Si, X., & Merlin, D. (2015) · Nanoscale · doi:10.1039/c5nr04831a · Cited by 152
Tefas, L. R., Sylvester, B., Tomuță, I., Sesărman, A., Licărete, E., Banciu, M., & Porfire, A. S. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s129008 · Cited by 144
Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells
Ma, J., Fang, B., Zeng, F., Pang, H., Zhang, J., Shi, Y., Wu, X., Cheng, L., Ma, C., Xia, J., et al. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.09.014 · Cited by 138
Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo.
Lv, Z., Liu, X., Zhao, W., Dong, Q., Li, F., Wang, H., & Kong, B. (2014) · PubMed Central · Cited by 137
Lotfi-Attari, J., Pilehvar‐Soltanahmadi, Y., Dadashpour, M., Alipour, S., Farajzadeh, R., Javidfar, S., & Zarghami, N. (2017) · Nutrition and Cancer · doi:10.1080/01635581.2017.1367932 · Cited by 132
Rao, K. M., Rao, K. S. V. K., Ramanjaneyulu, G., & Ha, C. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.001 · Cited by 123
Curcumin-loaded polymeric nanoparticles for enhanced anti-colorectal cancer applications
Udompornmongkol, P., & Chiang, B.-H. (2015) · Journal of Biomaterials Applications · doi:10.1177/0885328215594479 · Cited by 101
Chirio, D., Gallarate, M., Peira, E., Battaglia, L., Serpe, L., & Trotta, M. (2011) · Journal of Microencapsulation · doi:10.3109/02652048.2011.590615 · Cited by 98
Huang, J., Wang, K., Liu, Wang, Wu, Chen, Ni, Zhang, Junshu, & Hu (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s34702 · Cited by 96
Rahman, S., Cao, S., Steadman, K. J., Wei, M. Q., & Parekh, H. S. (2012) · Drug Delivery · doi:10.3109/10717544.2012.721143 · Cited by 89
Chaurasia, S., Chaubey, P., Patel, R. R., Kumar, N., & Mishra, B. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1064941 · Cited by 87
Sesărman, A., Tefas, L. R., Sylvester, B., Licărete, E., Rauca, V. F., Lupuţ, L., Pătraș, L., Banciu, M., & Porfire, A. S. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.10.004 · Cited by 85
Raveendran, R., Bhuvaneshwar, G. S., & Sharma, C. P. (2012) · Journal of Biomaterials Applications · doi:10.1177/0885328211427473 · Cited by 82
Shehzad, A., Lee, J., Huh, T., & Lee, Y. S. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0038-5 · Cited by 81
Abruzzo, A., Zuccheri, G., Belluti, F., Provenzano, S., Verardi, L., Bigucci, F., Cerchiara, T., Luppi, B., & Calonghi, N. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.05.023 · Cited by 78
Lei, Z., Fan, D., Yi, X., Cao, X., Chen, D., & Wang, L. (2014) · PubMed Central · Cited by 76
Natural products as inhibitors of carcinogenesis
Guilford, J. M., & Pezzuto, J. M. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.9.1341 · Cited by 71
Recent Progress in Studying Curcumin and its Nano-preparations for Cancer Therapy
Liu, J., Chen, S., Lv, L., Song, L., Guo, S., & Huang, S. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805289327 · Cited by 68
Abouzeid, A. H., Patel, N. R., Rachman, I. M., Senn, S., & Torchilin, V. P. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.840639 · Cited by 61
Pandelidou, M., DIMAS, K. S., Georgopoulos, A., Hatziantoniou, S., & Demetzos, C. (2011) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2011.3093 · Cited by 59
Chang, T., Trench, D., Putnam, J., Stenzel, M. H., & Lord, M. S. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00820 · Cited by 51
Supercritical carbon dioxide-developed silk fibroin nanoplatform for smart colon cancer therapy
Xie, M., Fan, D., Li, Y., He, X., Chen, X., Chen, Y., Zhu, J., Xu, G., Wu, X., & Lan, P. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s145012 · Cited by 50
Rejinold, N. S., Thomas, R. G., Muthiah, M., Chennazhi, K. P., Manzoor, K., Park, I., Jeong, Y. Y., & Jayakumar, R. (2014) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.11.044 · Cited by 45
Javadi, S., Rostamizadeh, K., Hejazi, J., Parsa, M., & Fathi, M. (2017) · Phytotherapy Research · doi:10.1002/ptr.5984 · Cited by 45
Chen, Y. C., Du, Q., Guo, Q., Huang, J., Liu, L., Shen, X., & Peng, J. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1539099 · Cited by 43
Chuah, L., Roberts, C. J., Billa, N., Abdullah, S., Rosli, R., & Manickam, S. (2013) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2013.800458 · Cited by 22
Self-citationDash, T. K., & Konkimalla, V. B. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12722 · Cited by 18
Effectiveness of Curcumin for Treating Cancer During Chemotherapy
Ferri, C., West, K., Otero, K., & Kim, Y. H. (2017) · Alternative and Complementary Therapies · doi:10.1089/act.2017.29147.yhk · Cited by 14
Cited by
Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy
Dehelean, C. A., Marcovici, I., Soica, C., Mioc, M., Coricovac, D., Iurciuc, S., Cretu, O. M., & Pinzaru, I. (2021) · Molecules · doi:10.3390/molecules26041109 · Cited by 502
Nanocurcumin: A Promising Candidate for Therapeutic Applications
Karthikeyan, A., Senthil, N., & Min, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00487 · Cited by 414
Biomedical Applications and Bioavailability of Curcumin—An Updated Overview
Sohn, S.-I., Priya, A., Balasubramaniam, B., Muthuramalingam, P., Sivasankar, C., Selvaraj, A., Valliammai, A., Jothi, R., & Pandian, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122102 · Cited by 305
Engineered nanoparticles for imaging and drug delivery in colorectal cancer
Pavitra, E., Dariya, B., Srivani, G., Kang, S.-M., Alam, A., Sudhir, P.-R., Kamal, M. A., Raju, G. S. R., Han, Y.-K., Lakkakula, B. V. K. S., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.017 · Cited by 102
Mitochondria‐associated endoplasmic reticulum membrane: Overview and inextricable link with cancer
Yang, X., Zhuang, J., Song, W., Shen, W., Wu, W., Shen, H., & Han, S. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17696 · Cited by 55
Metadata
- Authors
- Wong, K. E., Ngai, S. C., Chan, K.-G., Lee, L.-H., Goh, B.-H., & Chuah, L.-H.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2019-03-05
- Volume
- 10
- Pages
- 152-152
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2919262181
- Cited by
- 262
- References
- 69
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.